These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35160025)

  • 21. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDP-43 pathology in familial British dementia.
    Schwab C; Arai T; Hasegawa M; Akiyama H; Yu S; McGeer PL
    Acta Neuropathol; 2009 Aug; 118(2):303-11. PubMed ID: 19283396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDP-43 cytoplasmic inclusion formation is disrupted in
    Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
    Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
    Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
    Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
    King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
    Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
    Toyoshima Y; Takahashi H
    Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo.
    Riemenschneider H; Simonetti F; Sheth U; Katona E; Roth S; Hutten S; Farny D; Michaelsen M; Nuscher B; Schmidt MK; Flatley A; Schepers A; Gruijs da Silva LA; Zhou Q; Klopstock T; Liesz A; Arzberger T; Herms J; Feederle R; Gendron TF; Dormann D; Edbauer D
    Acta Neuropathol Commun; 2023 Jul; 11(1):112. PubMed ID: 37434215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43.
    Nonaka T; Masuda-Suzukake M; Hosokawa M; Shimozawa A; Hirai S; Okado H; Hasegawa M
    Hum Mol Genet; 2018 Aug; 27(15):2658-2670. PubMed ID: 29750243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
    Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
    Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological study of diffuse neurofibrillary tangles with calcification. With special reference to TDP-43 proteinopathy and alpha-synucleinopathy.
    Habuchi C; Iritani S; Sekiguchi H; Torii Y; Ishihara R; Arai T; Hasegawa M; Tsuchiya K; Akiyama H; Shibayama H; Ozaki N
    J Neurol Sci; 2011 Feb; 301(1-2):77-85. PubMed ID: 21106208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
    Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins.
    Kwong LK; Irwin DJ; Walker AK; Xu Y; Riddle DM; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2014 Mar; 2():33. PubMed ID: 24690345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
    Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
    Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Tsuji H; Nonaka T; Yamashita M; Masuda-Suzukake M; Kametani F; Akiyama H; Mann DM; Tamaoka A; Hasegawa M
    Biochem Biophys Res Commun; 2012 Jan; 417(1):116-21. PubMed ID: 22133678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.
    Clippinger AK; D'Alton S; Lin WL; Gendron TF; Howard J; Borchelt DR; Cannon A; Carlomagno Y; Chakrabarty P; Cook C; Golde TE; Levites Y; Ranum L; Schultheis PJ; Xu G; Petrucelli L; Sahara N; Dickson DW; Giasson B; Lewis J
    Acta Neuropathol; 2013 Jul; 126(1):39-50. PubMed ID: 23666556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
    Bosque PJ; Boyer PJ; Mishra P
    PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.